Research progress on antiviral therapy in hepatitis C-negative recipients receiving kidney transplantation from infected donors / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
; (6): 395-400, 2022.
Article
in Zh
| WPRIM
| ID: wpr-993712
Responsible library:
WPRO
ABSTRACT
Kidney transplantation is the best option for end stage renal disease. Currently, shortage of donor kidneys become a global problem for kidney transplants, partly due to the abandonment of kidneys from donors infected with hepatitis C virus (HCV). With the advent of direct-acting antiviral drugs, the use of HCV infected donor kidneys has become an important measure to expand the donor pool. This article reviews the research progress on the safety, efficacy and timing of antiviral therapy for HCV-negative recipients receiving kidney transplantation from HCV-positive donors.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Clinical Infectious Diseases
Year:
2022
Document type:
Article